drugset / Trial / NCT05684380
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of MAZ-101 in the treatment of moderate-severe persistent allergic rhinitis.
Timeline
- Start
- 2024-09
- Primary completion
- 2024-11
- Completion
- 2025-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DYMISTA® | Unknown | — | — |
| Subject | MAZ-101association | Unknown | — | — |